Epileptiform seizure after sertraline treatment in an adolescent experiencing obsessive-compulsive disorder and presenting a rare pharmacogenetic status.
Baumann
Pierre
P
Barbe
Rémy
R
Vabre-Bogdalova
Assia
A
Garran
Encarni
E
Crettol
Séverine
S
Eap
Chin B
CB
D000293:Adolescent; D014150:Antipsychotic Agents / Q000009:adverse effects; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics / Q000378:metabolism*; D004359:Drug Therapy, Combination; D004827:Epilepsy / Q000139:chemically induced*; D005260:Female; D005838:Genotype; D006801:Humans; D007527:Isoenzymes / Q000378:metabolism; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy*; D010597:Pharmacogenetics; D010641:Phenotype; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D020280:Sertraline / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use
D014150:Antipsychotic Agents; D003577:Cytochrome P-450 Enzyme System; D007527:Isoenzymes; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline